31 Jan
2019

The pharma fightback

With US pharmaceutical patents under greater threat than ever before, innovators are being forced to speak up for the rights that underpin their investment in crucial healthcare innovations

Adam Houldsworth

Life sciences reporter

IAM

[email protected]